According to the latest report published by Market Research Future (MRFR), the global superdisintegrants market size is set to exhibit a 7.9% CAGR during the forecast period. Disintegrants play a vital role in fast absorption of medicine in human body, which continue to drive their usage in various pharmaceutical products. Disintegrants increase the efficiency of medicines.
Superdisintegrants market are a superior version of the product achieved through modification. Superdisintegrants is a fast-growing segment is pharmaceutical industry. The global market for superdisintegrants is expected to surpass a valuation of USD 500 Mn by year end up from USD 371 in 2017.
The global pharmaceutical sector in growing at leaps and bounds. The growing patient pool worldwide and increased R&D efforts in the life science are among the key factors supporting the growth of sector. Rising in demand for medicines is linked with increased paediatric patients and geriatric patients. Such factors are propelling the global superdisintegrants market share.
Growth of the generic drugs industry due patent expiry of blockbuster drugs is opening new avenue of the growth. The pharmaceutical industry is witnessing a higher volume of new entrants especially in the generic drug segment. Emerging markets with larger pool of price-sensitive consumer present attractive opportunities for generic drugs industry. Market players must remain attentive of the fundamental changes in the pharmaceutical sector in order to remain competitive. Market players are realising the opportunities present in countries such China, India, ASEAN countries and GCC countries.
Global Superdisintegrants Market: Competition Analysis
Some of the top-notch companies operating in the market include Roquette Freres, Ashland Global Holdings Inc., Merck KGaA, Avantor Performance Materials, LLC, Asahi Kasei Corporation, BASF SE, DowDuPont Inc., DFE Pharma, Corel Pharma Chem and JRS Pharma.
Global Superdisintegrants Market: Segmental Analysis
Segmental analysis of the market has been conducted based on formulation, type, therapeutic area.
- Based on formulation, the market has been segmented into capsules and tablets. In terms of revenue, the tablets segment represents the larger market share. Meanwhile, the capsules segmented is projected to exhibit a higher CAGR.
- Based on type, the market has been segmented into natural disintegrants, synthetic superdisintegrants and others. Of these, the synthetic superdisintegrants segment is expected to remain highly attractive during the forecast period. This is mainly owing to widespread usage of synthetic superdisintegrants. The natural superdisintegrants segment is expected to find attractive growth opportunities in the forthcomoing years. This is mainly owing to growing preference for natural variants.
- Based on therapeutic area, the market has been segmented into neurological diseases, infectious diseases, hematological diseases, gastrointestinal diseases, cardiovascular diseases, inflammatory diseases and oncology. The gastrointestinal diseases segment accounts for the largest market share. The segment is likely to retain its dominant position over 2023. The oncology segment is projected to expand at the highest CAGR during the forecast period.
Global Superdisintegrants Market: Regional Analysis
The regions covered in the report include Asia Pacific (APAC), North America, Europe, Latin America and the Middle East & Africa (MEA).
North America led by the U.S. is expected to remain highly attractive during the forecast period. Robust healthcare system and high healthcare expenditure are amongst the key factors influencing the market growth in the region. Increased prevalence of chronic disorders is influencing the superdisintegrants market in the region.
Asia Pacific is viewed as emerging market for superdisintegrants. Increased healthcare penetration and growing healthcare expenditure in countries such as India and China is driving the market growth in the region. The APAC superdisintegrants market is projected to witness the fastest growth during the forecast period. In addition, higher emphasis on delivering quality healthcare likely to create market opportunities in the forthcoming years.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Email: [email protected]